Sentence examples for development of carrier from inspiring English sources

Possible solutions designed to minimize toxicity include the development of carrier systems able to modify the properties of the compounds and allow their controlled release.

The development of carrier clinics may improve access to information and support.

Thus, the development of carrier testing programs requires close collaboration with local institutions, leaders, individuals and healthcare providers.

This paper describes the experimental development of carrier buffalo and the role of gastrointestinal and urinary tracts of carrier buffalo in spreading HS.

In industrialized countries, such as the USA, where population-based carrier screening for individual disorders is widely accepted, the development of carrier screening utilizing NGS has focused on the capacity of the test to screen for recessive conditions [ 21].

Nevertheless, many examples in human and veterinary medicine indicate that the outcome of virus infection, development of carrier status, and shedding of virus are influenced by age and reproductive status, including stage of gestation at which infection occurs and the conferral to and duration of maternal immunity in progeny (15 ).

We believe the self-assembly approach demonstrated in this study can be applied to a variety of therapeutic peptide drugs to improve their stability and therapeutic activity for the development of carrier-free drug delivery system.

This swelling/deswelling process and the associated size can be used for the development of carriers for modulated drug delivery.

The results obtained provide important clues for the development of carriers for the sustainable delivery of bioactive compounds.

Aiming at contributing to the development of carriers for human usage a helicoid type sequential oligopeptide carrier, SOCn-II, formed by the repeating tetrapeptide unit (Aib-Lys-Aib-Gly)n, n = 2 7, elongated from the amino-terminus by the palmitoyl group, known for its adjuvanticity, is now presented.

As the range of the particles is only 28 100 µm in mammalian tissues, the development of carriers mediating specific uptake into the nucleus of tumor- or tumor endothelial cells is important to optimize therapeutic efficacy.